Inactive Instrument
Synergy Pharmaceuticals Inc Stock Nasdaq
Stocks
US8716393082
Biotechnology & Medical Research
| 1 day | -52.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Leslie M. Magnus
CTO | Chief Tech/Sci/R&D Officer | - | 2014-12-31 |
Stephen Comiskey
PRN | Corporate Officer/Principal | - | 2010-07-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -52.00% | -62.59% | - | - | 0 | |
| +0.41% | -2.07% | +41.26% | +95.40% | 68.87B | |
| +1.31% | +0.55% | +49.48% | +90.80% | 65.29B | |
| +0.04% | +4.36% | -11.72% | +459.54% | 27.65B | |
| +2.97% | +0.40% | +38.60% | +14.84% | 25.77B | |
| -0.90% | -7.65% | +2.45% | -15.50% | 26.08B | |
| +1.01% | +1.38% | +26.48% | -17.16% | 20.14B | |
| +3.45% | -13.46% | +222.69% | +389.50% | 17.03B | |
| +0.77% | -5.28% | -3.25% | +549.41% | 15.03B | |
| +1.03% | +7.00% | +59.98% | +160.03% | 14.5B | |
| Average | -4.19% | -1.83% | +47.33% | +191.87% | 31.15B | |
| Weighted average by Cap. | +0.98% | -1.19% | +42.63% | +149.98% |
Employees
-
